Literature DB >> 22596258

WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.

Qian Liu1, Haoqian Chen, Teresa Ojode, Xiangxi Gao, Sandra Anaya-O'Brien, Nicholas A Turner, Jean Ulrick, Rosamma DeCastro, Corin Kelly, Adela R Cardones, Stuart H Gold, Eugene I Hwang, Daniel S Wechsler, Harry L Malech, Philip M Murphy, David H McDermott.   

Abstract

WHIM syndrome is a rare, autosomal dominant, immunodeficiency disorder so-named because it is characterized by warts, hypogammaglobulinemia, infections, and myelokathexis (defective neutrophil egress from the BM). Gain-of-function mutations that truncate the C-terminus of the chemokine receptor CXCR4 by 10-19 amino acids cause WHIM syndrome. We have identified a family with autosomal dominant inheritance of WHIM syndrome that is caused by a missense mutation in CXCR4, E343K (1027G → A). This mutation is also located in the C-terminal domain, a region responsible for negative regulation of the receptor. Accordingly, like CXCR4(R334X), the most common truncation mutation in WHIM syndrome, CXCR4(E343K) mediated approximately 2-fold increased signaling in calcium flux and chemotaxis assays relative to wild-type CXCR4; however, CXCR4(E343K) had a reduced effect on blocking normal receptor down-regulation from the cell surface. Therefore, in addition to truncating mutations in the C-terminal domain of CXCR4, WHIM syndrome may be caused by a single charge-changing amino acid substitution in this domain, E343K, that results in increased receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22596258      PMCID: PMC3390956          DOI: 10.1182/blood-2011-12-395608

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting.

Authors:  A Marchese; J L Benovic
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

2.  Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence.

Authors:  Coralie Martin; Peter C E Burdon; Gary Bridger; Jose Carlos Gutierrez-Ramos; Timothy J Williams; Sara M Rankin
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

Review 3.  A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia.

Authors:  M Wetzler; M Talpaz; E S Kleinerman; A King; Y O Huh; J U Gutterman; R Kurzrock
Journal:  Am J Med       Date:  1990-11       Impact factor: 4.965

Review 4.  CXCR4 mutations in WHIM syndrome: a misguided immune system?

Authors:  George A Diaz
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

5.  The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression.

Authors:  M Rosu-Myles; L Gallacher; B Murdoch; D A Hess; M Keeney; D Kelvin; L Dale; S S Ferguson; D Wu; F Fellows; M Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 6.  CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.

Authors:  Magda Kucia; Kacper Jankowski; Ryan Reca; Marcin Wysoczynski; Laura Bandura; Daniel J Allendorf; Jin Zhang; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

7.  Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.

Authors:  Paolo A Hernandez; Robert J Gorlin; John N Lukens; Shoichiro Taniuchi; Joze Bohinjec; Fleur Francois; Mary E Klotman; George A Diaz
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

8.  Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome.

Authors:  Anna Virginia Gulino; Daniele Moratto; Silvano Sozzani; Patrizia Cavadini; Karel Otero; Laura Tassone; Luisa Imberti; Silvia Pirovano; Lucia D Notarangelo; Roberta Soresina; Evelina Mazzolari; David L Nelson; Luigi D Notarangelo; Raffaele Badolato
Journal:  Blood       Date:  2004-03-16       Impact factor: 22.113

9.  Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.

Authors:  William T Shearer; Howard M Rosenblatt; Rebecca S Gelman; Rebecca Oyomopito; Susan Plaeger; E Richard Stiehm; Diane W Wara; Steven D Douglas; Katherine Luzuriaga; Elizabeth J McFarland; Ram Yogev; Mobeen H Rathore; Wende Levy; Bobbie L Graham; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

10.  Chemokine requirements for B cell entry to lymph nodes and Peyer's patches.

Authors:  Takaharu Okada; Vu N Ngo; Eric H Ekland; Reinhold Förster; Martin Lipp; Dan R Littman; Jason G Cyster
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  28 in total

Review 1.  Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind.

Authors:  Bertrand Boisson; Pierre Quartier; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2015-01-31       Impact factor: 7.486

2.  Functional analyses of polymorphic variants of human terminal deoxynucleotidyl transferase.

Authors:  A Troshchynsky; I Dzneladze; L Chen; Y Sheng; V Saridakis; G E Wu
Journal:  Genes Immun       Date:  2015-06-04       Impact factor: 2.676

Review 3.  Genetics on a WHIM.

Authors:  Omar Al Ustwani; Razelle Kurzrock; Meir Wetzler
Journal:  Br J Haematol       Date:  2013-09-20       Impact factor: 6.998

4.  WHIM Syndrome Caused by Waldenström's Macroglobulinemia-Associated Mutation CXCR4 (L329fs).

Authors:  Qian Liu; Catherina Pan; Lizbeeth Lopez; Jiliang Gao; Daniel Velez; Sandra Anaya-O'Brien; Jean Ulrick; Patricia Littel; John S Corns; Donald T Ellenburg; Harry L Malech; Philip M Murphy; David H McDermott
Journal:  J Clin Immunol       Date:  2016-04-08       Impact factor: 8.317

Review 5.  Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Authors:  Philip M Murphy; Lauren Heusinkveld
Journal:  Cytokine       Date:  2018-02-15       Impact factor: 3.861

6.  G Protein-Coupled Receptor Kinase 3 and Protein Kinase C Phosphorylate the Distal C-Terminal Tail of the Chemokine Receptor CXCR4 and Mediate Recruitment of β-Arrestin.

Authors:  Jiansong Luo; John M Busillo; Ralf Stumm; Jeffrey L Benovic
Journal:  Mol Pharmacol       Date:  2017-03-22       Impact factor: 4.436

7.  Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.

Authors:  Jia Wu; Wei Zhang; Aiqiang Xu; Li Zhang; Tao Yan; Zhuo Li; Xiaopan Wu; Xilin Zhu; Juan Ma; Ke Li; Hui Li; Ying Liu
Journal:  Genet Test Mol Biomarkers       Date:  2013-06-22

8.  Preference of Genetic Diagnosis of CXCR4 Mutation Compared with Clinical Diagnosis of WHIM Syndrome.

Authors:  Asghar Aghamohammadi; Hassan Abolhassani; Jacek Puchalka; Naschla Greif-Kohistani; Samaneh Zoghi; Christoph Klein; Nima Rezaei
Journal:  J Clin Immunol       Date:  2017-03-28       Impact factor: 8.317

9.  Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors.

Authors:  Concepción Gómez-Moutón; Thierry Fischer; Rosa M Peregil; Sonia Jiménez-Baranda; Thomas P Stossel; Fumihiko Nakamura; Santos Mañes
Journal:  Blood       Date:  2014-10-29       Impact factor: 22.113

10.  Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.

Authors:  Lauren E Heusinkveld; Erin Yim; Alexander Yang; Ari B Azani; Qian Liu; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  Expert Opin Orphan Drugs       Date:  2017-09-25       Impact factor: 0.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.